Currently prescribed drugs in the UK that could upregulate or downregulate ACE2 in COVID-19 disease: a systematic review. (2020)

First Author: Dambha-Miller H
Attributed to:  Epidemiological contribution to primary and secondary prevention of diabetes and obesity funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2020-040644

PubMed Identifier: 32928868

Publication URI: http://europepmc.org/abstract/MED/32928868

Type: Journal Article/Review

Volume: 10

Parent Publication: BMJ open

Issue: 9

ISSN: 2044-6055